Showing results (31-40 of 958) with videos related to

Sort By:
Pageof 96
Acta Radiologica. Oncology|January 1, 1981
Effect of pepleomycin on peripheral lymphocytesH Blomgren, F Edsmyr, L E Strender
Urological Research|January 1, 1978
Orgotein (superoxide dismutase): a drug for the amelioration of radiation-induced side effects. A double-blind, placebo-controlled study in patients with bladder tumoursK B Menander-Huber, F Edsmyr, W Huber
Urological Research|January 1, 1978
Radiation treatment of urinary bladder carcinomaF Edsmyr, P L Esposti, G Giertz, et al.
Acta Radiologica. Oncology|January 1, 1983
Spontaneous cytotoxicity of blood lymphocytes following local radiation therapy for carcinoma of the urinary bladderH Blomgren, F Edsmyr, P L Esposti, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
Immunological and haematological monitoring in bladder cancer patients receiving adjuvant bestatin treatment following radiation therapy. A prospective randomized trialH Blomgren, F Edsmyr, P L Esposti, et al.
Urological Research|January 1, 1978
Blood coagulation studies in patients with advanced carcinoma of the prostate treated with 2,6-cis-diphenylhexamethylcyclotetrasiloxane or estramustine-17-phosphateM Blombäck, F Edsmyr, C Kockum, et al.
Urological Research|January 1, 1982
Prediction of survival and recurrence in bladder carcinomaB Nilsson, B Wahren, P L Esposti, et al.
The Journal of Urology|December 1, 1978
Clinical experimental randomized study of 2.6-cis-diphenylhexamethylcyclotetrasiloxane and estramustine-17-phosphate in the treatment of prostatic carcinomaF Edsmyr, P L Esposti, B Johansson, et al.
Scandinavian Journal of Gastroenterology|January 1, 1979
Possible tumour markers in patients with oesophagus cancerB Wahren, J Harmenberg, F Edsmyr, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
Bestatin treatment enhances the recovery of radiation induced impairments of the immunological reactivity of the blood lymphocyte population in bladder cancer patientsH Blomgren, F Edsmyr, L V von Stedingk, et al.
Pageof 96